These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11884499

  • 1. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G, Mang'era K, Liu N, Gupta S, Rusckowski M, Hnatowich DJ.
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [Abstract] [Full Text] [Related]

  • 2. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Liu G, He J, Dou S, Gupta S, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
    [Abstract] [Full Text] [Related]

  • 3. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
    Liu G, He J, Dou S, Gupta S, Vanderheyden JL, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
    [Abstract] [Full Text] [Related]

  • 4. Investigations of 99mTc morpholino pretargeting in mice.
    Liu G, Liu C, Zhang S, He J, Liu N, Gupta S, Rusckowski M, Hnatowich DJ.
    Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607
    [Abstract] [Full Text] [Related]

  • 5. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
    Liu G, Dou S, He J, Liu X, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
    [Abstract] [Full Text] [Related]

  • 6. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
    He J, Liu G, Gupta S, Zhang Y, Rusckowski M, Hnatowich DJ.
    J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
    Liu G, Zhang S, He J, Liu N, Gupta S, Rusckowski M, Hnatowich DJ.
    Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
    Chen X, Dou S, Liu G, Liu X, Wang Y, Chen L, Rusckowski M, Hnatowich DJ.
    Bioconjug Chem; 2008 Aug; 19(8):1518-25. PubMed ID: 18646837
    [Abstract] [Full Text] [Related]

  • 12. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO, Liu G, Yi W, Zhang Y, Liu N, Gupta S, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [Abstract] [Full Text] [Related]

  • 13. Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.
    Liu G, Dou S, Chen X, Chen L, Liu X, Rusckowski M, Hnatowich DJ.
    Cancer Biother Radiopharm; 2010 Dec; 25(6):757-62. PubMed ID: 21204772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
    Liu G, Dou S, Pretorius PH, Liu X, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):272-80. PubMed ID: 17909792
    [Abstract] [Full Text] [Related]

  • 18. 90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
    Liu G, Dou S, Liu Y, Wang Y, Rusckowski M, Hnatowich DJ.
    Bioconjug Chem; 2011 Dec 21; 22(12):2539-45. PubMed ID: 21985267
    [Abstract] [Full Text] [Related]

  • 19. Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.
    Yao Z, Zhang M, Axworthy DB, Wong KJ, Garmestani K, Park L, Park CW, Mallett RW, Theodore LJ, Yau EK, Waldmann TA, Brechbiel MW, Paik CH, Pastan I, Carrasquillo JA.
    Cancer Res; 2002 Oct 15; 62(20):5755-60. PubMed ID: 12384535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.